top of page

FREE SHIPPING ON ALL ORDERS OVER $300

  • SARMACEUTICALS YK-11 Myostine

SARMACEUTICALS YK-11 Myostine

C$90.00Price

Overview: YK-11, also known as Myostine, is a unique compound that exhibits properties of both selective androgen receptor modulators (SARMs) and myostatin inhibitors. Its primary mechanism involves partial activation of androgen receptors in muscle and bone tissue while also increasing follistatin levels, which inhibits myostatin. Unlike other SARMs, YK-11 is structurally similar to dihydrotestosterone (DHT) and demonstrates a more potent anabolic effect at lower doses. This dual action mechanism potentially offers greater muscle-building effects than traditional SARMs while minimizing androgenic side effects.

 

Benefits:

  • Enhanced Muscle Growth: Promotes rapid lean muscle mass development through myostatin inhibition.
  • Improved Strength: Facilitates significant strength gains due to its potent anabolic effects.
  • Bone Density Support: May support bone health by enhancing bone cell proliferation and mineralization.
  • Fat Loss: Potentially aids in reducing body fat while preserving muscle tissue.
  • Potential Therapeutic Applications: Demonstrates promise in treating muscle wasting conditions and osteoporosis.

 

Dosage and Usage: 30mL bottle, 20mg/mL

Standard dosing for research purposes ranges from 2-5 mg per day. Administration is typically recommended twice daily due to its shorter half-life compared to other SARMs. Common research cycles last between 4-8 weeks.

 

Ingredients: YK-11 (Myostine), Solvents (DMSO, Propylene Glycol, Vegetable Glycerin) USP Grade

Additional Information: YK-11 is produced under stringent quality control standards, ensuring high purity and consistency. Each batch undergoes rigorous analytical testing to verify its composition and efficacy.

 

Disclaimer: This product is intended solely for laboratory research use only. Not for human consumption. Not for human or veterinary diagnostic or therapeutic use. Users should consult relevant literature and adhere to appropriate protocols. Not suitable for non-research use or by individuals under 18 years of age.

    bottom of page